OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The significance of the cholinergic system in the brain during aging and in Alzheimer’s disease
Reinhard Schliebs, Thomas Arendt
Journal of Neural Transmission (2006) Vol. 113, Iss. 11, pp. 1625-1644
Closed Access | Times Cited: 506
Reinhard Schliebs, Thomas Arendt
Journal of Neural Transmission (2006) Vol. 113, Iss. 11, pp. 1625-1644
Closed Access | Times Cited: 506
Showing 1-25 of 506 citing articles:
Alzheimer's disease: Targeting the Cholinergic System
Talita H. Ferreira‐Vieira, Isabella G. Olmo, Flávia Rodrigues da Silva, et al.
Current Neuropharmacology (2016) Vol. 14, Iss. 1, pp. 101-115
Open Access | Times Cited: 1282
Talita H. Ferreira‐Vieira, Isabella G. Olmo, Flávia Rodrigues da Silva, et al.
Current Neuropharmacology (2016) Vol. 14, Iss. 1, pp. 101-115
Open Access | Times Cited: 1282
The cholinergic system in aging and neuronal degeneration
Reinhard Schliebs, Thomas Arendt
Behavioural Brain Research (2010) Vol. 221, Iss. 2, pp. 555-563
Closed Access | Times Cited: 969
Reinhard Schliebs, Thomas Arendt
Behavioural Brain Research (2010) Vol. 221, Iss. 2, pp. 555-563
Closed Access | Times Cited: 969
Therapeutics of Alzheimer's disease: Past, present and future
R. Anand, Kiran Dip Gill, Abbas Ali Mahdi
Neuropharmacology (2013) Vol. 76, pp. 27-50
Closed Access | Times Cited: 717
R. Anand, Kiran Dip Gill, Abbas Ali Mahdi
Neuropharmacology (2013) Vol. 76, pp. 27-50
Closed Access | Times Cited: 717
Connections between sleep and cognition in older adults
Kristine Yaffe, Cherie Falvey, Tina Hoang
The Lancet Neurology (2014) Vol. 13, Iss. 10, pp. 1017-1028
Closed Access | Times Cited: 684
Kristine Yaffe, Cherie Falvey, Tina Hoang
The Lancet Neurology (2014) Vol. 13, Iss. 10, pp. 1017-1028
Closed Access | Times Cited: 684
Pharmaceutical and medicinal significance of sulfur (SVI)-Containing motifs for drug discovery: A critical review
Chuang Zhao, K.P. Rakesh, L. Ravidar, et al.
European Journal of Medicinal Chemistry (2018) Vol. 162, pp. 679-734
Open Access | Times Cited: 484
Chuang Zhao, K.P. Rakesh, L. Ravidar, et al.
European Journal of Medicinal Chemistry (2018) Vol. 162, pp. 679-734
Open Access | Times Cited: 484
Down syndrome: Cognitive and behavioral functioning across the lifespan
Julie A. Grieco, Margaret B. Pulsifer, Karen Seligsohn, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2015) Vol. 169, Iss. 2, pp. 135-149
Closed Access | Times Cited: 381
Julie A. Grieco, Margaret B. Pulsifer, Karen Seligsohn, et al.
American Journal of Medical Genetics Part C Seminars in Medical Genetics (2015) Vol. 169, Iss. 2, pp. 135-149
Closed Access | Times Cited: 381
ComplementC3-Deficient Mice Fail to Display Age-Related Hippocampal Decline
Qiaoqiao Shi, Kenneth J. Colodner, Sarah B. Matousek, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 38, pp. 13029-13042
Open Access | Times Cited: 333
Qiaoqiao Shi, Kenneth J. Colodner, Sarah B. Matousek, et al.
Journal of Neuroscience (2015) Vol. 35, Iss. 38, pp. 13029-13042
Open Access | Times Cited: 333
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)
Javier Egea, Isabel Fabregat, Yves‐Michel Frapart, et al.
Redox Biology (2017) Vol. 13, pp. 94-162
Open Access | Times Cited: 297
Javier Egea, Isabel Fabregat, Yves‐Michel Frapart, et al.
Redox Biology (2017) Vol. 13, pp. 94-162
Open Access | Times Cited: 297
Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer’s pathology
Taylor W. Schmitz, R. Nathan Spreng, Michael W. Weiner, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 284
Taylor W. Schmitz, R. Nathan Spreng, Michael W. Weiner, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 284
Innovative diagnostic tools for early detection of Alzheimer's disease
Christoph Laske, Hamid R. Sohrabi, Shaun Frost, et al.
Alzheimer s & Dementia (2014) Vol. 11, Iss. 5, pp. 561-578
Closed Access | Times Cited: 277
Christoph Laske, Hamid R. Sohrabi, Shaun Frost, et al.
Alzheimer s & Dementia (2014) Vol. 11, Iss. 5, pp. 561-578
Closed Access | Times Cited: 277
Atrophy of the Cholinergic Basal Forebrain Over the Adult Age Range and in Early Stages of Alzheimer's Disease
Michel J. Grothe, Helmut Heinsen, Stefan Teipel
Biological Psychiatry (2011) Vol. 71, Iss. 9, pp. 805-813
Open Access | Times Cited: 264
Michel J. Grothe, Helmut Heinsen, Stefan Teipel
Biological Psychiatry (2011) Vol. 71, Iss. 9, pp. 805-813
Open Access | Times Cited: 264
Synthetic approaches and pharmaceutical applications of chloro-containing molecules for drug discovery: A critical review
Wan‐Yin Fang, Ravindar Lekkala, K.P. Rakesh, et al.
European Journal of Medicinal Chemistry (2019) Vol. 173, pp. 117-153
Open Access | Times Cited: 220
Wan‐Yin Fang, Ravindar Lekkala, K.P. Rakesh, et al.
European Journal of Medicinal Chemistry (2019) Vol. 173, pp. 117-153
Open Access | Times Cited: 220
Therapeutics of Neurotransmitters in Alzheimer’s Disease
Ramesh Kandimalla, P. Hemachandra Reddy
Journal of Alzheimer s Disease (2017) Vol. 57, Iss. 4, pp. 1049-1069
Open Access | Times Cited: 218
Ramesh Kandimalla, P. Hemachandra Reddy
Journal of Alzheimer s Disease (2017) Vol. 57, Iss. 4, pp. 1049-1069
Open Access | Times Cited: 218
Alkaloids as a source of potential anticholinesterase inhibitors for the treatment of Alzheimer's disease
Eduardo Luis Konrath, Carolina dos Santos Passos, Luiz Carlos Klein‐Júnior, et al.
Journal of Pharmacy and Pharmacology (2013) Vol. 65, Iss. 12, pp. 1701-1725
Closed Access | Times Cited: 207
Eduardo Luis Konrath, Carolina dos Santos Passos, Luiz Carlos Klein‐Júnior, et al.
Journal of Pharmacy and Pharmacology (2013) Vol. 65, Iss. 12, pp. 1701-1725
Closed Access | Times Cited: 207
Cholinergic Differentiation of Human Neuroblastoma SH-SY5Y Cell Line and Its Potential Use as an In vitro Model for Alzheimer’s Disease Studies
Liana Marengo de Medeiros, Marco Antônio De Bastiani, Eduardo Pacheco Rico, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 11, pp. 7355-7367
Closed Access | Times Cited: 173
Liana Marengo de Medeiros, Marco Antônio De Bastiani, Eduardo Pacheco Rico, et al.
Molecular Neurobiology (2019) Vol. 56, Iss. 11, pp. 7355-7367
Closed Access | Times Cited: 173
The Role of Estrogen in Brain and Cognitive Aging
Jason K Russell, Carrie K. Jones, Paul Newhouse
Neurotherapeutics (2019) Vol. 16, Iss. 3, pp. 649-665
Open Access | Times Cited: 165
Jason K Russell, Carrie K. Jones, Paul Newhouse
Neurotherapeutics (2019) Vol. 16, Iss. 3, pp. 649-665
Open Access | Times Cited: 165
Innervation of the gastrointestinal tract: Patterns of aging
Robert Phillips, Terry L. Powley
Autonomic Neuroscience (2007) Vol. 136, Iss. 1-2, pp. 1-19
Open Access | Times Cited: 267
Robert Phillips, Terry L. Powley
Autonomic Neuroscience (2007) Vol. 136, Iss. 1-2, pp. 1-19
Open Access | Times Cited: 267
Methylene blue and Alzheimer's disease
Murat Öz, Dietrich E. Lorke, Georg Petroianu
Biochemical Pharmacology (2009) Vol. 78, Iss. 8, pp. 927-932
Closed Access | Times Cited: 250
Murat Öz, Dietrich E. Lorke, Georg Petroianu
Biochemical Pharmacology (2009) Vol. 78, Iss. 8, pp. 927-932
Closed Access | Times Cited: 250
Neurobiology of Alzheimer′s disease
E. Mohandas, V Rajmohan, B Raghunath
Indian Journal of Psychiatry (2009) Vol. 51, Iss. 1, pp. 55-55
Open Access | Times Cited: 248
E. Mohandas, V Rajmohan, B Raghunath
Indian Journal of Psychiatry (2009) Vol. 51, Iss. 1, pp. 55-55
Open Access | Times Cited: 248
Smoking, nicotine and neuropsychiatric disorders
Péter Döme, Judit Lazáry, Miklós Péter Kalapos, et al.
Neuroscience & Biobehavioral Reviews (2009) Vol. 34, Iss. 3, pp. 295-342
Closed Access | Times Cited: 213
Péter Döme, Judit Lazáry, Miklós Péter Kalapos, et al.
Neuroscience & Biobehavioral Reviews (2009) Vol. 34, Iss. 3, pp. 295-342
Closed Access | Times Cited: 213
Estrogen Therapy and Cognition: A Review of the Cholinergic Hypothesis
Robert B. Gibbs
Endocrine Reviews (2010) Vol. 31, Iss. 2, pp. 224-253
Open Access | Times Cited: 193
Robert B. Gibbs
Endocrine Reviews (2010) Vol. 31, Iss. 2, pp. 224-253
Open Access | Times Cited: 193
Pharmacodynamic, Pharmacokinetic and Pharmacogenetic Aspects of Drugs Used in the Treatment of Alzheimer’s Disease
Muriel Noetzli, Chin B. Eap
Clinical Pharmacokinetics (2013) Vol. 52, Iss. 4, pp. 225-241
Closed Access | Times Cited: 192
Muriel Noetzli, Chin B. Eap
Clinical Pharmacokinetics (2013) Vol. 52, Iss. 4, pp. 225-241
Closed Access | Times Cited: 192
HT22 hippocampal neuronal cell line possesses functional cholinergic properties
Jun Liu, Longxuan Li, William Z. Suo
Life Sciences (2008) Vol. 84, Iss. 9-10, pp. 267-271
Closed Access | Times Cited: 186
Jun Liu, Longxuan Li, William Z. Suo
Life Sciences (2008) Vol. 84, Iss. 9-10, pp. 267-271
Closed Access | Times Cited: 186
Lipid Rafts and Alzheimer’s Disease: Protein-Lipid Interactions and Perturbation of Signaling
David A. Hicks, Natalia N. Nalivaeva, Anthony J. Turner
Frontiers in Physiology (2012) Vol. 3
Open Access | Times Cited: 184
David A. Hicks, Natalia N. Nalivaeva, Anthony J. Turner
Frontiers in Physiology (2012) Vol. 3
Open Access | Times Cited: 184
The involvement of nitric oxide synthase neurons in enteric neuropathies
Leni R. Rivera, Daniel P. Poole, Michelle Thacker, et al.
Neurogastroenterology & Motility (2011) Vol. 23, Iss. 11, pp. 980-988
Closed Access | Times Cited: 177
Leni R. Rivera, Daniel P. Poole, Michelle Thacker, et al.
Neurogastroenterology & Motility (2011) Vol. 23, Iss. 11, pp. 980-988
Closed Access | Times Cited: 177
